They currently have a $72.0000 target price on Bristol Myers (NYSE:BMY). Guggenheim’s target would suggest a …
As such, Arfaei reiterates an Underperform rating on Bristol Myers shares, while …
Technical Stock Analysis Bristol-Myers Squibb Company (NYSE:BMY), a Healthcare sector firm, traded 14.98 Million …
PHILADELPHIA, March 29, 2018 /PRNewswire/ -- Kehoe Law Firm, P.C. is investigating claims on behalf of investors of Bristol-Myers Squibb Company (NYSE: BMY) to determine whether Bristol-Myers and certain of its officers and/or …
The stock price continued to fall on the next trading day, declining another $2.98 per share, or 4.7%, on unusually heavy trading volume, to close at $60.30 per share on August 8, 2016. Even after the announcement of August 5, 2016, …
What was the reason Bristol-Myers Squibb Co (NYSE ... Article printed from InvestorPlace Media, https://investorplace.com/2018/02/bym-stock-earnings-selloff/.